Clinical Trial

HPV Detection Using Self-Collected Menstrual Blood

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is evaluating whether human papillomavirus (HPV) can be accurately detected from self-collected menstrual blood samples. Participants who have had routine clinical HPV testing within the previous 90 days will collect a menstrual blood sample at home using a study-provided collection kit. The HPV test result from the menstrual blood sample will be compared with the participant's prior clinical HPV test result to assess agreement between the two methods. The goal is to determine whether menstrual blood collection may provide a feasible, noninvasive approach for HPV testing.
Trial Details
NCT Number NCT07733557
Lead Sponsor Samantha Batman
Collaborators: Endometrics
Conditions Human Papillomavirus (HPV) Infection
Enrollment 50 participants
Start Date 2026-07
Primary Completion 2029-07 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-29